Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right
by WannabeRockstar
Patient back to baseline. Vitals stable. . Sent to...
A Cost Analysis of Bleed Complications from Two Stroke Prev
A Cost Analysis of Bleed Complications from Two Stroke Prev
by giovanna-bartolotta
valvular. Atrial Fibrillation. :. Left Atrial Ap...
Sumith Aleti , MD, MPH, FACC
Sumith Aleti , MD, MPH, FACC
by dorothy
OHHI Cardiology Group. Antiplatelet and Anticoagul...
To tPA or not to tPA
To tPA or not to tPA
by tatyana-admore
To tPA or not to tPA ? Answers to the question ...
Treatments in Ischemic Stroke:
Treatments in Ischemic Stroke:
by trinity
Current and Future. Published in journal of Europe...
Stratifying stroke risk to guide antithrombotic therapy in patients with AF
Stratifying stroke risk to guide antithrombotic therapy in patients with AF
by davies
No evidence that AF type significantly impacts str...
We believe that you may be having an ischemic stroke Alteplase ttA
We believe that you may be having an ischemic stroke Alteplase ttA
by samantha
that we can give you to help treat your stroke. W...
HEMORRHAGIC STROKE DONE BY
HEMORRHAGIC STROKE DONE BY
by madison
Assist. Lect. . Shaymaa. . Hasan. Abbas. DESIRED...
LAA Closure Devices: Protecting Against Stroke
LAA Closure Devices: Protecting Against Stroke
by debby-jeon
Moderator. Ted E. Feldman, MD. Director. Cardiac ...
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
by dsuser1
Christopher Granger, . MD. Sean Pokorney, MD. . D...
Kenneth W. Mahaffey, MD,
Kenneth W. Mahaffey, MD,
by myesha-ticknor
on behalf of the TRACER Investigators and Committ...
Kenneth W. Mahaffey, MD,
Kenneth W. Mahaffey, MD,
by cheryl-pisano
on behalf of the TRACER Investigators and Committ...
Updates in Anticoagulation:
Updates in Anticoagulation:
by test
What Did We Learn From ESC 2017?. COMPASS: . Tria...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). .  . If your reuse request...
Randomized Open Label
Randomized Open Label
by roberts
A MulticenterStudy of Oral Anticoagulationwith or ...
Common Stroke Medications
Common Stroke Medications
by Kingslayer
Type. of Medication. Generic Names. Brand Name. P...
x0000x0000 For more information call 18553547847 1855
x0000x0000 For more information call 18553547847 1855
by eddey
�� Call your doctor or health...
ENT EMERGENCIES M AL-HASHIM
ENT EMERGENCIES M AL-HASHIM
by hadly
Common ENT emergencies. Basic management . How to ...
Antiplatelet
Antiplatelet
by sherrill-nordquist
Therapy for the Secondary Prevention of . Cerebr...
Antiplatelet
Antiplatelet
by kittie-lecroy
Therapy for the Secondary Prevention of . Cerebr...
Strokes/Seizures
Strokes/Seizures
by conchita-marotz
STS. 4/13/2015. Cerebrovascular Accident & St...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
WATCHMAN™ Left Atrial Appendage Closure Device
WATCHMAN™ Left Atrial Appendage Closure Device
by alexa-scheidler
www.watchmandevice.com. AF is a Growing Problem A...
Neurological conditions
Neurological conditions
by luanne-stotts
. S. troke. Trigeminal . neuralgia. Myasthenia G...
Journal Club Jim Hoehns,
Journal Club Jim Hoehns,
by cheryl-pisano
Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...
Michael D. Ezekowitz, MBChB
Michael D. Ezekowitz, MBChB
by alida-meadow
, DPhil,. FACC, FAHA, FRCP, MA. Professor, Sidney...
UPDATEDPRACTICE
UPDATEDPRACTICE
by singh
Pharmacologic Management of Newly Detected Atria...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
CEREBRO VASCULAR ACCEDANT (CVA)
CEREBRO VASCULAR ACCEDANT (CVA)
by heavin
Dr.Zaid Al-Nasrawi. Trauma and Orthopedics surgery...
Outcomes Associated With
Outcomes Associated With
by daisy
Resuming Warfarin Treatment After . Hemorrhagic St...
Aspirin (n = 6,610) Ticagrelor
Aspirin (n = 6,610) Ticagrelor
by danya
(n . = 6,589). SOCRATES. Primary outcome, death, M...
Study Background and Rationale
Study Background and Rationale
by cecilia
Updated October 24, . 2018. Apixaban for the Reduc...
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
by adah
NOAC vs Warfarin Atrial Fibrillation Studies – A...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
Oral anticoagulants in the 21
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Dodson Thompson, DO
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
ANTICOAGULATION Blake Wachter
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
Reduction in Ischemic Events with
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...